ARTICLE | Company News
Bionomics, Hybrigen deal
September 24, 2001 7:00 AM UTC
The companies signed a letter of intent to research breast cancer targets. Hybrigen will use its proteomics technologies to identify protein targets that interact with two genes identified by BNO, TSG...